Ctgf clinical trial
WebMay 20, 2014 · 4138 Background: CTGF is overexpressed in PDAC and facilitates local desmoplasia, tumor survival and metastasis. FG-3019 is a CTGF-specific monoclonal antibody that decreases tumor growth and metastases and prolongs survival in the KPC mouse model of pancreatic cancer. This study evaluated safety and efficacy of FG-3019 … WebDec 15, 2008 · FibroGen, Inc. today announced that an open-label, phase 1 clinical trial designed to evaluate the safety and tolerability of FG-3019, a fully human monoclonal antibody against connective tissue growth factor (CTGF), in combination with gemcitabine and erlotinib in patients with locally advanced or metastatic pancreatic …
Ctgf clinical trial
Did you know?
WebNov 17, 2015 · Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular … WebConnective tissue growth factor (CTGF) is a glycoprotein thought to interact with regulatory modulators such as transforming growth factor-β (TGF- β); this elicits cellular …
WebConnective tissue growth factor (CTGF) from basics to clinics Authors Yasaman Ramazani 1 , Noël Knops 2 , Mohamed A Elmonem 3 , Tri Q Nguyen 4 , Fanny Oliveira Arcolino 1 , Lambert van den Heuvel 5 , Elena Levtchenko 2 , Dirk Kuypers 6 , Roel Goldschmeding 7 Affiliations WebMay 25, 2024 · Introduction. Connective tissue growth factor (CTGF, CCN2), a cysteine-rich matricellular protein, is an important profibrotic mediator in several fibrotic disorders, including idiopathic pulmonary fibrosis (IPF) (1, 2).In IPF, promising results of the PRAISE trial were recently published, which was a phase II randomized trial of Pamrevlumab …
WebPamrevlumab, our proprietary fully human antibody, targets connective tissue growth factor (CTGF), the central mediator of tissue remodeling and fibrosis. Pamrevlumab … WebFeb 25, 2024 · FG-3019 (pamrevlumab) is a human monoclonal antibody (mAb) against CTGF that has shown efficacy in a randomized, placebo-controlled phase 2 clinical trial in subjects with idiopathic pulmonary fibrosis , as well as in phase 2 clinical trials for treatment of pancreatic cancer and Duchenne muscular dystrophy (NCT02210559 and …
WebJun 6, 2012 · CTGF is a secreted matricellular protein with very complex biology. It has been shown to modulate many signaling pathways leading to cell adhesion and migration, …
WebCharacterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes David A Brott,1 Stephen T Furlong,1 Scott H Adler,1 James W Hainer,2 Ramin B Arani,2 Mark Pinches,3 Peter Rossing,4–6 Nish Chaturvedi7 On behalf of the DIRECT Programme Steering … rowlands castle railway stationWebFeb 17, 2024 · Pamrevlumab, a connective tissue growth factor (CTGF) inhibitor, is now being dosed in patients with IPF participating in the ZEPHYRUS-2 phase 3 trial. ... rowlands castle pharmacy ukPurpose: Pancreatic ductal adenocarcinomas exhibit a high degree … rowlands castle road closureWebGCSF is an FDA-approved drug used to increase white blood cell counts in patients receiving chemotherapy. TrialNet researchers wanted to know if ATG alone or in … stream wyze cam free web browserWebFeb 2, 2014 · Clinically, CTGF expression correlates with melanoma progression and metastasis. Inhibition of CTGF, either genetically or with a specific anti-CTGF … rowlands castle golf courseWebOct 14, 2014 · Connective tissue growth factor is a new ligand of epidermal growth factor receptor. J. Mol. Cell Biol. 5, 323–335 (2013). CAS PubMed Google Scholar Cheng, X. et … rowlands castle neighbourhood planWebConnective-tissue growth factor (CTGF), also known variously as CCN2 (Cyr61 [cysteine-rich protein 61] and NOV [nephroblastoma overexpressed gene], ... Results of a randomized, double-blind, placebo-controlled phase 2 clinical trial testing pamrevlumab in IPF patients, PRAISE (prospective randomized amlodipine survival evaluation), ... stream xbox games from console to pc